FDA DEVICE FACTS
RENASYS DYNAFLOW Kit (66807741)
Smith & Nephew Medical, Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The RENASYS DYNAFLOW system is intended to be used in conjunction with Smith + Nephew RENASYS EDGE and RENASYS TOUCH NPWT for the application of negative pressure wound therapy to the wound to promote wound management by the delivery of saline to the wound bed and removal of fluids (including saline, irrigation fluids, body fluids, wound exudates and infectious material). For patients who would benefit from vacuum assisted drainage and controlled delivery of saline over the wound bed. The RENASYS DYNAFLOW device is intended for use in the clinical setting by clinicians. Appropriate wound types include: chronic, acute, traumatic, sub-acute and dehisced wounds, ulcers (such as pressure and diabetic), partial-thickness burns, flaps, and grafts.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。